IJuul Labs ithe ngoLwesine ithole uxhaso kubatshalizimali bokuqala nokuthi ihlela ukunciphisa ingxenye yesithathu yabasebenzi bayo ukuze iqhubeke nokusebenza.
"Namuhla, iJuul Labs isisungule indlela eya phambili, eyenziwe yenzeka ngokufakwa kwemali kwabanye babatshalizimali bethu bokuqala," kusho ummeleli uJuul etshela i-CNBC. "Ngalolu xhaso lwezimali, iJuul Labs izokwazi ukuqhubeka nebhizinisi layo, iphishekele isikhalazo sayo sokuphatha ngesinqumo se-FDA sokuphika ukumaketha, futhi ikhuthaze ukusungulwa komkhiqizo kanye nokukhiqizwa kwesayensi."
Inkampani ayizange idalule noma yiluphi ulwazi mayelana nokutshalwa kwezimali noma imigomo yayo.
UJuul umemezele ukuthi ukuze aqhubekele phambili futhi aqhubeke nokusebenza, kuzodingeka “ahlele kabusha” abasebenzi bakhe bomhlaba. Le nkampani ihlose ukudiliza abasebenzi ababalelwa ku-400 futhi yehlise isabelomali sayo sokusebenza ngamaphesenti angama-30 sibe ngamaphesenti angama-40.
UJuul uhlangabezane nobunzima bezezimali ezikhathini zamuva nje. Yethula idumela layo ugwayi kagesi ngo-2015, ukumaketha njengendlela engcono yokubhema ugwayi ovamile. Selokhu inkampani ibhekane nezinkinga zomthetho eziningi. UJuul uxazulule izikhalazo eziningi ezinkulu ezethulwe iziphathimandla zezwe, iningi lazo okuthiwa ngamasu okuthengisa adukisayo kanye nokwehluleka ukuxwayisa ngobungozi bezimpahla zayo.
Isivumelwano size ngaphambi kocwaningo lwakamuva oluvela ku-Food and Drug Administration kanye neCenters for Disease Control and Prevention, okutholwe ukuthi ugwayi we-elekthronikhi uzoba umkhiqizo we-nicotine osetshenziswa kakhulu phakathi kwabafundi basesikoleni esiphakathi nesesikoleni esiphakeme unyaka wesishiyagalolunye olandelanayo ngo-2022. Ngokusekelwe ejensi, cishe abafundi abayizigidi ezi-3.1 badle imikhiqizo kagwayi kulo nyaka wesikole. Ugwayi we-elekthronikhi wawusetshenziswa abantu abangaphezu kwezigidi ezingu-2.5.
Ngokocwaningo, izici ezihlukahlukene, okuhlanganisa okuthandwayo, ukukhangisa, nemibono eyiphutha ngengozi, kuholela ekusetshenzisweni komkhiqizo kagwayi wentsha.
I-FDA iyalele uJuul ukuthi ayeke ukuhlinzeka ngemishini yayo yokukhipha umoya kulo nyaka, kodwa i-oda lamiswa okwesikhashana ngoJulayi. Ingqikithi yenkampani yalimala ngenxa yokudumazeka, futhi abahlaziyi babikezela ukuthi izofuna ukuvikelwa kokuqothuka ngaphansi kweSahluko 11 njengendlela yokuphuma.
